Mirja Wessel

USPTO Granted Patents = 19 (Patent Applications = 8)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 31)

Average Co-Inventor Count = 4.5

ph-index = 7

Forward Citations = 82(Granted Patents)

Company Filing History:

Evonik Operations Gmbh

patents

Years Active: 2014-2024

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11993803 - Mixture composition comprising glucolipids (2024-05-28),

2. 11685905 - Rhamnolipid-producing cell having reduced glucose dehydrogenase activity (2023-06-27),

3. 11236372 - Lipid production (2022-02-01),

4. 11034938 - Microorganism expressing mutant AlkB enzyme and use to prepare omega-hydroxy carboxylic acid and/or ester (2021-06-15),

5. 10745721 - Process for reacting a carboxylic acid ester (2020-08-18),

6. 10174353 - Methods of producing rhamnolipids (2019-01-08),

7. 9765370 - Method for aerobically producing alanine or a compound produced using alanine (2017-09-19),

8. 9725746 - Producing amines and diamines from a carboxylic acid or dicarboxylic acid or a monoester thereof (2017-08-08),

9. 9719117 - Production of omega-amino fatty acids (2017-08-01),

10. 9655934 - Dermatologically effective yeast extract (2017-05-23),

11. 9611489 - Enzymatic omega-oxidation and omega-amination of fatty acids (2017-04-04),

12. 9580720 - Cells and methods for producing rhamnolipids (2017-02-28),

13. 9249435 - Process for the improved separation of a hydrophobic organic solution from an aqueous culture medium (2016-02-02),

14. 9157108 - Cells, nucleic acids, enzymes and use thereof, and methods for the production of sophorolipids (2015-10-13),

15. 9102968 - Cells, nucleic acids, enzymes and use thereof, and methods for the production of sophorolipids (2015-08-11),

Title: Mirja Wessel - Innovator in Glucolipid Research

Introduction

Mirja Wessel, based in Bochum, Germany, is a prominent inventor with a remarkable portfolio that includes 19 patents. Her innovative contributions primarily focus on glucolipids and biotechnological processes, which have significant implications in various applications, including formulation science and microbial production.

Latest Patents

Among her latest patents, Wessel has developed a mixture composition comprising glucolipids. This invention details the formulation of a mixture comprising glucolipids and highlights its utility for producing formulations that incorporate this composition. Additionally, she has patented a genetically modified rhamnolipid-producing cell with reduced glucose dehydrogenase activity. This invention involves cells engineered to produce rhamnolipids, featuring a decreased activity level of glucose dehydrogenase compared to their wild-type counterparts. The method described for producing rhamnolipids underscores her expertise in both biotechnology and chemical processes.

Career Highlights

Mirja Wessel has had a noteworthy career, having worked with leading companies in the chemical and biotechnology sectors. She has contributed her expertise during her tenure at Evonik Degussa GmbH and Evonik Operations GmbH, where she furthered her research and innovation in the field.

Collaborations

Throughout her career, Wessel has collaborated with talented professionals, including Steffen Schaffer and Anja Thiessenhusen. These collaborations have likely enriched her research endeavors, allowing for a multidisciplinary approach to innovation.

Conclusion

Mirja Wessel's body of work and her numerous patents reflect her dedication to advancing research in glucolipid applications and biotechnological innovation. Her contributions continue to impact industries related to formulation and microbial production, marking her as a significant figure in her field.

This text is generated by artificial intelligence and may not be accurate.